Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer: Anticipating A Game-Changer Soon
10:52am, Wednesday, 09'th Apr 2025
I reaffirm my Buy rating on Pfizer due to expected promising updates on danuglipron and strong capital efficiency metrics, despite the recent stock pullback. Pfizer's management is expected to annou
5 Low Price-to-Book Stocks to Add to Your Portfolio in April
10:01am, Wednesday, 09'th Apr 2025
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, JD, PFE, STNE and ENS are some such stocks.
Pfizer: Best-In-Class Dividend Yield Together With Dirt Cheap Valuation
10:00am, Wednesday, 09'th Apr 2025
Pfizer's 7.5% dividend yield is safe due to revenue growth, cost efficiency, and a stronger balance sheet, making it a strong buy. Pfizer's innovation in R&D, including AI partnerships and new drug ap
S&P 500: Pharma Giants Lead Decline as Tariff Threats Rattle Pfizer, Merck, Johnson & Johnson
09:50am, Wednesday, 09'th Apr 2025
Pharmaceutical stocks tumble as Trump announces imminent “major tariff” on imported drugs. Pfizer, Merck, and Johnson & Johnson shares drop over 4%, dragging the broader S&P 500 lower.
3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
05:32am, Wednesday, 09'th Apr 2025
If you're a dividend investor, now can be an ideal time to go bargain-hunting. The stock market is in the midst of a broad sell-off, with investors dumping all types of stocks, both bad ones and good
5 Tariff Sell-Off Casualties That Now Pay 7% and Higher Dividends
01:47pm, Tuesday, 08'th Apr 2025
Investors love dividend stocks, especially high-yield varieties, because they offer a significant income stream and have substantial total return potential.
Is Pfizer (PFE) Stock Undervalued Right Now?
10:46am, Tuesday, 08'th Apr 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Down 62%, Should You Buy the Dip on Pfizer?
04:40am, Tuesday, 08'th Apr 2025
Pharmaceutical giant Pfizer (PFE -1.42%) was a big winner during the COVID-19 pandemic. Its vaccine and antiviral pill generated billions of dollars in sales.
Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes
09:40am, Monday, 07'th Apr 2025
Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.
4 Dividend Stocks to Double Up on Right Now
08:15am, Saturday, 05'th Apr 2025
Most people don't like seeing stock prices go down. It triggers a very natural emotional response associated with pain and loss.
4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners
04:44pm, Friday, 04'th Apr 2025
With some pharmaceutical stocks paying 4% and higher dividends, they may be the perfect total return idea for the rest of 2025.
NEW YORK--(BUSINESS WIRE)--Entwistle & Cappucci LLP (“Entwistle & Cappucci”) today announced that its ongoing investigation has led to the filing of a class action (the “Action”) against Cerev
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)
01:01pm, Friday, 04'th Apr 2025
1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)
GSK resolves patent lawsuit against Pfizer over RSV vaccines
06:03pm, Thursday, 03'rd Apr 2025
British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in its c
JNJ vs. PFE: Which Drug Giant is a Better Buy Now?
11:00am, Thursday, 03'rd Apr 2025
Both JNJ & PFE expect their sales and profits to improve in 2025.
